Legal Representation
Attorney
Matthew A. Homyk
USPTO Deadlines
Next Deadline
533 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210706)
Due Date
July 06, 2027
Grace Period Ends
January 06, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 6, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 2, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 1, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 17, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 14, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 14, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jan 9, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 7, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 7, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 7, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 20, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 20, 2020 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Aug 19, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 7, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 19, 2020 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jul 7, 2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Aug 3, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 7, 2020 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jul 7, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 7, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 12, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 12, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 23, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 3, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 27, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 27, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 27, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 27, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 25, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 16, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 12, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Classification
International Classes
005